Baird Medical Investment Holdings ( (BDMD) ) has released a notification of late filing.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Baird Medical Investment Holdings Limited has announced a delay in filing its Form 20-F (Yearly Report) for the fiscal year ending December 31, 2024. The delay is primarily due to the need for additional time to prepare and review its consolidated financial statements. The company expects to file the report within the 15-day extension period allowed by the SEC. There are no anticipated significant changes in the financial results from the previous year, and the company has included forward-looking statements regarding potential risks and uncertainties. The notification was signed by Haimei Wu, the Chairwoman and CEO, indicating ongoing compliance efforts.
More about Baird Medical Investment Holdings
YTD Price Performance: 16.21%
Average Trading Volume: 85,578
Technical Sentiment Signal: Buy
Current Market Cap: $210.9M
For an in-depth examination of BDMD stock, go to TipRanks’ Stock Analysis page.